AT275037B - Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen - Google Patents
Verfahren zur Herstellung von Mitteln zur Hemmung von ImmunitätsreaktionenInfo
- Publication number
- AT275037B AT275037B AT926367A AT926367A AT275037B AT 275037 B AT275037 B AT 275037B AT 926367 A AT926367 A AT 926367A AT 926367 A AT926367 A AT 926367A AT 275037 B AT275037 B AT 275037B
- Authority
- AT
- Austria
- Prior art keywords
- agents
- manufacture
- immune reactions
- inhibiting immune
- inhibiting
- Prior art date
Links
- 230000008105 immune reaction Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB45695/66A GB1136039A (en) | 1966-10-12 | 1966-10-12 | Improvements relating to immunosuppressive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AT275037B true AT275037B (de) | 1969-10-10 |
Family
ID=10438194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT926367A AT275037B (de) | 1966-10-12 | 1967-10-12 | Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen |
Country Status (6)
Country | Link |
---|---|
AT (1) | AT275037B (xx) |
BE (1) | BE705035A (xx) |
ES (1) | ES345979A1 (xx) |
FR (2) | FR1552939A (xx) |
GB (1) | GB1136039A (xx) |
NL (1) | NL6713800A (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4043869A (en) | 1972-07-13 | 1977-08-23 | Koch-Light Laboratories, Ltd. | Water insoluble biologically active material |
ES2759252T3 (es) | 2013-10-31 | 2020-05-08 | Resolve Therapeutics Llc | Fusiones y métodos terapéuticos de nucleasa-albúmina |
-
1966
- 1966-10-12 GB GB45695/66A patent/GB1136039A/en not_active Expired
-
1967
- 1967-10-11 FR FR1552939D patent/FR1552939A/fr not_active Expired
- 1967-10-11 NL NL6713800A patent/NL6713800A/xx unknown
- 1967-10-11 ES ES345979A patent/ES345979A1/es not_active Expired
- 1967-10-11 FR FR124050A patent/FR7058M/fr not_active Expired
- 1967-10-12 AT AT926367A patent/AT275037B/de active
- 1967-10-12 BE BE705035D patent/BE705035A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR7058M (xx) | 1969-06-23 |
BE705035A (xx) | 1968-04-12 |
GB1136039A (en) | 1968-12-11 |
NL6713800A (xx) | 1968-04-16 |
ES345979A1 (es) | 1968-12-01 |
FR1552939A (xx) | 1969-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH487916A (de) | Verfahren zur Herstellung von 2-Cycloalkylamino-oxazolinen | |
CH484108A (de) | Verfahren zur Herstellung von Pyrrylaminoäthanolen | |
CH490294A (de) | Verfahren zur Herstellung von 3-Methylpentenen | |
CH485731A (de) | Verfahren zur Herstellung von 3-Amino-4-carboxamidopyrazol | |
CH479626A (de) | Verfahren zur Herstellung von Organooxysilanen | |
CH484016A (de) | Verfahren zur Herstellung von Hydrindacenen | |
CH491064A (de) | Verfahren zur Herstellung von Diaceton-L-sorbose | |
CH487177A (de) | Verfahren zur Herstellung von Thiaimidazolidinen | |
CH484155A (de) | Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden | |
CH491857A (de) | Verfahren zur Herstellung von Phenoxyaminoalkanolen | |
AT275037B (de) | Verfahren zur Herstellung von Mitteln zur Hemmung von Immunitätsreaktionen | |
CH490358A (de) | Verfahren zur Herstellung von 17a-Äthinyl-17B-hydroxysteroiden | |
CH472381A (de) | Verfahren zur Herstellung von Monohalogeno- azeto-azetamiden | |
AT277957B (de) | Verfahren zur Herstellung von Alkenonen | |
CH490377A (de) | Verfahren zur Herstellung von Aminohydrinen | |
CH495333A (de) | Verfahren zur Herstellung von Trihalogenäthylglycinaten | |
CH477470A (de) | Verfahren zur Herstellung von Ribofuranosiden | |
CH487860A (de) | Verfahren zur Herstellung von Arylsulfonylsemicarbaziden | |
CH509249A (de) | Verfahren zur Herstellung von 3-Aminoalkyl-3-arylindanolen-1 | |
CH506556A (de) | Verfahren zur Herstellung von Chinolylmethylpenicillinen | |
CH480435A (de) | Verfahren zur Herstellung von N-Demethyl-N-äthyllincomycin C | |
AT276763B (de) | Verfahren zur Herstellung von Polyacyloxamidrazonen | |
AT273165B (de) | Verfahren zur Herstellung von Diphenylsilandiolen | |
AT269873B (de) | Verfahren zur Herstellung von 2-Nitroimidazolen | |
AT274780B (de) | Verfahren zur Herstellung von 1-Acylaminoadamantanen |